SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

Abattis Bioceuticals Corp. (ATTBF)

ATTBF RSS Feed
Add ATTBF Price Alert      Hide Sticky   Hide Intro
Moderator: Goodbuddy4863, guay, captainscotty, ebota12, GreenBrickRoad, Campeese
Search This Board: 
Last Post: 5/25/2017 4:53:54 PM - Followers: 319 - Board type: Free - Posts Today: 0




Welcome to Abattis Bioceuticals Corp.
 

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), is a specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets.

Through our divisions Biocell Labs Inc. and Vergence Sales & Marketing Group, we develop and license natural health products and have future plans to expand into the nutraceutical, pharmaceutical and cosmetic markets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding natural health product market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.





Within our other divisions Northern Vine, North American Bioextracts and Biocube we have capabilities that support the production and extraction of botanical ingredients for our products; one of which includes cannabis.

Northern Vine LaboratoriesTM (Northern Vine Labs
TM) seeks to become the premier analytical testing laboratory, and research and development partner to the legal cannabis industry in Canada - Executive Overview

For more information, visit the Company's website at: www.abattis.com.





Our investors are forward thinkers in the emerging bioceutical and medical marijuana markets. We are a specialty, vertically-integrated biotechnology company that aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. From patented and proprietary formulations, extraction and processing methods, Abattis consistently seeks opportunities to participate in varied markets all connected by a common global purpose and customer base: seeking health through natural products. Abattis is uniquely positioned to fully exploit the growing trend toward marijuana legalization in the United States and medicinal use in Canada as licensed and international jurisdictions.





 

“Health Canada estimates that the emerging medical marijuana market to be in excess of $1 billion.
Stephen Easton, an SFU Economist, estimated that nationally the Cannabis industry generates approximately $19 to $21 billion”



We develop and license natural health products with unique botanical blends, CBD and proprietary ingredients. These infused food and beverage brands are designed for wellness nutraceuticals, medical foods & botanical drugs market with future plans to expand into the pharmaceutical and cosmetic markets.





 

Canada’s cannabis industry is expected to surpass $22 billion in size over the coming years, according to Deloitte, with over 140,000 registered medical marijuana patients today. With about 40 licensed producers under the ACMPR, the industry is expected to see a shortfall in supply given the 205% compound annual growth rate in registered patients since June of 2014 along with the near-term plans to legalize marijuana for recreational use.



As an investor, you are our partner and we take this relationship seriously. Please contact us if you have any questions or if you would like to invest in Abattis.

Goldman Small Cap Research report, 'This Stock Set to Double Thanks to New License'
Abattis Bioceuticals Corp. - Stock Up Big on Recent News, Greater Gains on Horizon (October 20, 2016).

Goldman Small Cap Research report 
'The Next Industry-Changing Specialty Health Stock'
Abattis Bioceuticals Corp. - Major Revenue Ahead for Innovative, Diversified Bioceuticals Pioneer (June 13, 2016).


 
Northern Vine Labs™ is getting ready for our launch.

Visit our website and join our community for updates and educational information.
#knowyourbud #abattis #northernvinelabs 




 

Northern Vine Labs™ are now on Health Canada list for licensed dealers!
The table below contains a list of laboratories that have a current Dealers Licence under the Narcotic Control Regulations and who are licensed to conduct activities with cannabis:






Northern Vine Labs™, a subsidiary of Abattis, seeks to become the premier analytical testing laboratory, and research and development partner to the legal cannabis industry in Canada. The ability to legally work with Cannabis remains rare and highly specialized. Northern Vine Labs™ Controlled Substance License enables proprietary methods and services to be offered to currentlicensed producers within Canada’s existing Federal regulatory structure. It also offers Northern Vine Labs™ customers, including Abattis, the ability to formulate and develop new products containing cannabinoid ingredients in advance of the end to prohibition.

In partnership with the BC Institute of Technology (BCIT), Northern Vine Labs™ has been working to develop new and improved methods for the analysis of cannabis. This work is expected to be published by BCIT positioning NV Labs as the industry expert in analytical services which are substantially faster and more reliable than any other in Canada. Utilizing these proprietary methods, Northern Vine Labs will offer for sale its analytical reference standards enabling market participants to check quality and metrological traceability of products, to validate analytical measurement methods, and/or to support the proper calibration of instruments.

 
Northern Vine Labs™ operations under the CSL will include:
1. Analytical Services
2. Research and Development Services
3. Extraction to Support Analysis and R&D?
In future, NV Labs anticipates the opportunity to amend its license to include:
4. Extraction service for sale of extracted ingredients
5. Importation/Exportation

Analytical Services
Potency Testing Determining composition and concentration of various cannabinoid compounds
Moisture Analysis and Foreign Matter Testing
Microbiological Testing
Ensuring the safety of products by testing for levels of mold and bacteria.

The Cannabis Trade Alliance of Canada, which represents producers, said the new regime should provide for mandatory testing: 

“Mandatory laboratory testing of all cannabis products (potency and contaminants) – a critical step in the seed-to-sale process when considering public health, and should be the main objective in the legalized framework.”

Report of the Task Force on Cannabis Legalization and Regulation


 





Vergence Visionary Bioceuticals, a subsidiary of Abattis, is a team of nutraceutical marketing and brand specialists focused on innovative health products to penetrate the fast growing market for natural, safe and effective solutions to two of society’s unresolved and ubiquitous health issues: Pain caused by inflammation and mental ailments common to our modern lifestyle. Vergence is the exclusive exporter of 99.6%, organic and pure CBD Isolate out of Hong Kong and directly to the rest of the world. Together with a vast distribution network and custom product and branded formulations via Northern Vine Labs, Vergence aims to promote healthy living through natural remedies. Vergence is in possession of over 100 Natural Product Numbers (NPN's) as granted by Health Canada and plans to develop and distribute these products into global markets for end use.




Abattis Bioceuticals Corporation
Address: 104 - 9295 198th Street | Langley, BC V1M 3J9 | Canada
Phone: 778-883-7869 (Corporate Communications: Brook Bellian)
Email: news@abattis.com
Website: http://www.abattis.com


Abattis Bioceuticals
Phone: (604) 336.0881

Northern Vine
Phone: 
(604) 336.0881 | (604) 371.3371 | (604) 888.1129

CHINA | Dr. Shuang Xie  Ph. D.
Suzhou Raybot Material Tech Ltd
T: 17785884380 | C: 17783175968
Phone: 86 5125240581 | 8613901388668
Address:  No. 10-1 Yang Yuan Road,
Xinzhuang Zhen,Changshu | China



OUTSTANDING COMMON SHARE DATA
There are an unlimited number of common shares without par value authorized for issue. At September 30, 2016, there were 111,760,004 issued and fully paid common shares and 1,750,000 common shares in treasury.

Issued & Outstanding (03/19/2017)The Company has 144,321,560 common shares issued and outstanding (source
 

System for Electronic Document Analysis and Retrieval (SEDAR) - www.sedar.com






 

05/10/2017 | Northern Vine Labs Expands Its Sales Team
05/03/2017 | Official Launch of Northern Vine Laboratory
04/26/2017 | Abattis Signed Exclusive Destribution Agreement
04/10/2017 | Abattis Bioceuticals Announces New CEO
04/06/2017 | Abattis Gets Added to the Marijuana Index by MJIC
04/04/2017 | Near-term Legalization Puts Testing into Focus
03/27/2017 | Next Month - Legislation to Legalize Marijuana in CA
03/20/2017 | Dr. David Galvez - New Science Advisor of Northern Vine
03/13/2017 | Abattis Team Positions for Next Stage of Growth
03/07/2017 | LP Highlights Continued Need for Testing
02/25/2017 | Abattis Prepares to Launch Northern Vine Labs
02/24/2017 | Abattis Annual Report - September 30, 2016
02/14/2017 | Abattis Audit Update
02/08/2017 | Key Shortcomings in Canada's Cannabis Industry
02/03/2017 | Abattis Audit Update
12/16/2016 | Abattis Provides Corporate Update
12/09/2016 | $ 5 Million Facility with Aluminia Partners
11/15/2016 | Dr. Shuang Xie - Director and CTA
11/09/2016 | Licensing Deal and Brand Acouisition
11/07/2016 | Renewal of Health Canada Licence
11/02/2016 | Appointment of New Independent Director
10/24/2016 | Agreement to Acquire 100% of Experion
10/17/2016 | Experion Prepares for Construction
10/05/2016 | MOU with Global Damon Pharma of South Korea
10/03/2016 | Northern Vine Receives Controlled Substance Licence









If you want to add or to change something on this site - send a message to guay.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ATTBF
Current Price
Volume:
Bid Ask Day's Range
ATTBF News: Withdrawal of Registration Statement (rw) 12/09/2016 06:05:17 AM
PostSubject
#29659  Sticky Note ABATTIS ANNOUNCES THE OFFICIAL LAUNCH OF NORTHERN VINE LABORATORY oatsuzn 05/03/17 01:05:05 PM
#29239  Sticky Note ABATTIS BIOCEUTICALS: Joins an Index and Runs with captainscotty 04/16/17 08:15:16 AM
#28851  Sticky Note READ!!!: Abattis Bioceuticals Announces New CEO Vancouver, British Columbia--(N StockWhale 04/10/17 10:12:58 AM
#28505  Sticky Note ATTBF Now Listed on the Marijuana Index-Biotechnology sector: Goodbuddy4863 04/02/17 07:18:06 PM
#27284  Sticky Note Goldman Research thinks ATTBF could blow through $0.30+ GreenBrickRoad 10/21/16 11:19:22 AM
#26399  Sticky Note Corporate Update ebota12 11/05/15 07:31:44 PM
#12064  Sticky Note BOARD WARNING - Please Read: IH Admin [Shelly] 06/09/14 01:18:32 PM
#29872   Well... I can't fault your spirit and you dangerx 05/25/17 04:53:54 PM
#29871   Ouch! Names hurt my feelings. To answer your ebota12 05/25/17 03:57:12 PM
#29870   Why the fuck would I want to help you dangerx 05/25/17 03:15:09 PM
#29869   That's a great idea danger - if you ebota12 05/25/17 01:44:00 PM
#29868   People don't get paid til tomorrow. Anyone struggling dangerx 05/25/17 11:13:48 AM
#29867   I am sure the less chatter is due Skittles9 05/25/17 09:49:46 AM
#29866   I would like to sell but not this ebota12 05/24/17 09:07:13 PM
#29865   Extreme and "scary price fluctuations" ... just another guay 05/24/17 06:45:16 PM
#29864   Dangerx, by the time you typed it, it Skittles9 05/24/17 05:39:48 PM
#29863   Back to .16... dangerx 05/24/17 03:40:16 PM
#29862   Just broke $.14... SeeingGreen420 05/24/17 02:38:39 PM
#29861   Another solid stand at 0.15. GreenBrickRoad 05/24/17 01:42:58 PM
#29860   We'll see. jdstearns1 05/24/17 11:35:15 AM
#29859   What do you mean hold until good news Skittles9 05/23/17 09:21:13 PM
#29858   And the $.15 line still stands. If we SeeingGreen420 05/23/17 12:13:13 PM
#29857   Whew that's a blast from the past. GreenBrickRoad 05/23/17 11:41:26 AM
#29856   http://marijuanastockinvestor.com/marijuana-stock-otc-attbf-a-dream-coming-true/ 420toInfinity 05/23/17 01:25:18 AM
#29855   #ATTBF: Looking strong by any measurement...:-] $0.15 captainscotty 05/22/17 05:22:56 PM
#29854   Everything is fiiiine everybody! If you dont believe 420toInfinity 05/22/17 04:32:04 PM
#29853   There will be up days and down days. Goodbuddy4863 05/22/17 10:32:14 AM
#29852   looking stagnant..... Lvannoy88 05/22/17 10:25:43 AM
#29851   Just checking in. Goodbuddy4863 05/22/17 01:16:49 AM
#29850   Finally at 15! Time to load uuuuuuuuuuuup!!! 420toInfinity 05/20/17 06:53:35 PM
#29849   No chance they dominate the test market. Further, guay 05/20/17 05:36:08 PM
#29848   That's my point. Cannabis can be transported. That's ebota12 05/20/17 07:06:11 AM
#29847   You think they're one of 5. I ebota12 05/20/17 07:05:04 AM
#29846   I know what he's trying to say, are oatsuzn 05/19/17 09:25:31 PM
#29845   I think what he's saying is that it's Lvannoy88 05/19/17 09:08:08 PM
#29844   What does that have to do with cannabis? oatsuzn 05/19/17 08:51:03 PM
#29843   My employer buys parts from China and India. ebota12 05/19/17 08:44:00 PM
#29842   Interesting to see what happens Monday ending at SeeingGreen420 05/19/17 07:25:07 PM
#29841   Still holding $.15... SeeingGreen420 05/19/17 03:05:35 PM
#29840   You mean the other less than 5 labs oatsuzn 05/19/17 12:41:24 PM
#29839   They need deals in place though, some real SeeingGreen420 05/19/17 12:32:02 PM
#29838   The best PR will be the one with cdaniel394 05/19/17 12:26:50 PM
#29837   I'm sure NV will issue a PR the ebota12 05/19/17 11:43:48 AM
#29836   Pretty much. I just hope we aren't GreenBrickRoad 05/19/17 11:41:20 AM
#29835   We will see, without news we are stuck SeeingGreen420 05/19/17 08:39:07 AM
#29834   You should have spent the last 2 days Skittles9 05/19/17 08:38:27 AM
#29833   Last two days spent trying to pick up L Ticks 05/19/17 07:08:39 AM
#29832   ATTBF staying within the 0.15-0.17 range, but I'll GreenBrickRoad 05/17/17 04:25:59 PM
#29831   MM jdstearns1 05/17/17 12:05:37 PM
#29830   Bid .166 Ask .171 Nice strong start - ATTBF SeeingGreen420 05/17/17 09:20:04 AM
#29829   Some nice buys here, with few exceptions. ebota12 05/16/17 01:55:21 PM
#29828   Dead board walking. RobotDroid 05/16/17 11:36:49 AM
#29827   It's Easy Being Green … guay 05/16/17 08:33:17 AM
#29826   Not from what I see, new low on RobotDroid 05/15/17 01:43:34 PM
#29825   A lot of nice buying going on today, ATTBF SeeingGreen420 05/15/17 12:25:43 PM
#29824   The barrier at 0.15 has held. guay 05/12/17 06:18:55 PM
#29823   a small up trend has been born The dead cat bouncer 05/12/17 02:02:33 PM
PostSubject